CAY10404 - HY-121537
Nur noch %1 verfügbar
Catalog #
HY-121537
Ab
93,00 €
CAY10404 is a potent and selective cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 1 nM and a selectivity index (SI; COX-1 IC50/COX-2 IC50) of >500000. CAY10404 is a potent PKB/Akt and MAPK signaling pathways inhibitor and induces apoptosis in non-small cell lung cancer (NSCLC) cells. CAY10404, a diarylisoxazole, has good analgesic, anti-inflammatory, and anti-cancer activities[1][2][3].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-121537/CAY10404-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | COVID-19-immunoregulation |
| CAS | 340267-36-9 |
| Storage | -20°C (Powder, stored under nitrogen) |
| MWT | 367.34 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Akt;Apoptosis;COX |
| Application: | COVID-19-immunoregulation |
|---|